Market Newsdesk

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP alerts investors in Hercules Capital, Inc. (NYSE: HTGC) of a pending securities class action naming two senior officers as individual defendants. Class Period: May 1, 2025 through February 27, 2026. Check if you can recover your investment losses or contact Joseph E. Levi, Esq. at [email protected] | (212) 363-7500.

HTGC shares fell $1.22 per share, or 7.9%, on February 27, 2026, closing at $14.21 on unusually heavy volume. The Court has set May 19, 2026 as the deadline to apply for lead plaintiff appointment.

The Named Individual Defendants

Scott Bluestein, Chief Executive Officer and Chief Investment Office, and Seth H. Meyer, Chief Financial Officer, are both named as defendants in the action filed in the U.S. District Court for the Northern District of California. The lawsuit asserts that both executives possessed the power and authority to control the contents of Hercules Capital’s SEC filings, press releases, and investor presentations throughout the Class Period.

Section 20(a) Control Person Framework

The action contends that Bluestein and Meyer, by virtue of their senior positions, had access to material non-public information about the Company’s deal sourcing practices, valuation team staffing, and software debt classification. As alleged, they knew adverse facts had not been disclosed to the investing public while positive representations about the Company’s “disciplined underwriting” and “rigorous” origination process were being disseminated.

• Bluestein headed the investment origination team of more than 50 professionals and allegedly oversaw the deal sourcing pipeline described in SEC filings
• Meyer, as CFO, was responsible for the accuracy of financial reporting, including NAV calculations and portfolio fair value determinations
• Both executives had the ability and opportunity to prevent the issuance of allegedly misleading statements or cause them to be corrected
• Both signed or certified quarterly and annual SEC filings throughout the Class Period that described a multistep Board-approved valuation process

Sarbanes-Oxley Certification Obligations

Under Sections 302 and 906 of the Sarbanes-Oxley Act, Bluestein and Meyer each personally certified the accuracy of the Company’s quarterly 10-Q filings and the FY25 10-K annual report. These certifications covered the very valuation procedures and deal origination disclosures that the complaint challenges as materially misleading.

“Corporate officers have a duty to ensure their companies’ public statements are accurate and complete. When executives personally certify SEC filings describing a rigorous, multistep valuation process, investors are entitled to rely on those representations.” — Joseph E. Levi, Esq.

Speak with an attorney about recovering damages
or call (212) 363-7500.

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services’ Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Ed Korsinsky, Esq. 33 Whitehall Street, 27th Floor New York, NY 10004 [email protected] Tel: (212) 363-7500 Fax: (212) 363-7171

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP reminds purchasers of Camping World Holdings, Inc. (NYSE: CWH) securities of a pending securities class action.

THE CASE: A class action seeks to recover damages for investors who purchased CWH securities between April 29, 2025 and February 24, 2026.

YOUR OPTIONS: You may be entitled to compensation without payment of any out-of-pocket fees. See if you can recover losses or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

From a closing price of $16.82 on October 28, 2025, CWH shares fell to $12.65 per share the following day, a single-session loss of $4.17 per share, or 24.8%. Then, from $10.85 on February 24, 2026, shares declined to $9.06 on February 25, 2026, an additional loss of $1.79 per share, or 16.5%. Both sessions traded on unusually heavy volume. The last day to move for lead plaintiff is May 11, 2026.

The October 28, 2025 After-Hours Disclosure

The market repriced CWH shares after the Company reported third quarter 2025 results revealing that new vehicle revenue had declined $58.1 million, or 7.0%, to $766.8 million, with average selling prices dropping 8.6%. Total gross margin contracted 27 basis points to 28.6%. These figures contradicted the optimistic portrayal of consumer demand and inventory positioning that had supported CWH’s share price throughout the first half of the year, the lawsuit maintains.

The February 24, 2026 Corrective Admission

The remaining artificial inflation was allegedly removed when the Company disclosed fourth quarter 2025 results that exposed the full scope of the deterioration:

• Net loss widened to $109.1 million, an increase of $49.6 million, or 83.3%, over the prior year quarter
• Adjusted EBITDA swung to a loss of $26.2 million, worsening by $23.7 million
• Gross profit declined $38.7 million, or 10.3%, with total gross margin falling 247 basis points to 28.8%
• New vehicle gross margin fell 291 basis points to 12.3%; used vehicle gross margin fell 277 basis points to 16.0%
• SG&A as a percent of gross profit improved only 190 basis points, far below the 300 to 400 basis points the Company had guided
• The Company paused its quarterly cash dividend, effective immediately

Alleged Investor Damages and Loss Causation

The complaint asserts that the market price of CWH common stock was artificially inflated throughout the Class Period because management’s public statements concealed known inventory management failures, overstated consumer demand, and misrepresented the Company’s ability to achieve stated SG&A targets. As these concealed realities surfaced across two corrective disclosures, the market removed the alleged artificial inflation, costing shareholders $4.17 per share in October 2025 and an additional $1.79 per share in February 2026.

“When companies fail to disclose material information, shareholders may suffer significant losses. The combined per-share decline across two corrective events raises substantial questions about the accuracy of representations made to the investing public during this Class Period.” — Joseph E. Levi, Esq.

Join the CWH recovery action or call Joseph E. Levi, Esq. at (212) 363-7500.

ABOUT LEVI & KORSINSKY, LLP — Over the past 20 years, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyndryl investors who were adversely affected by alleged securities fraud between August 1, 2024 and February 9, 2026. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/kyndryl-holdings-lawsuit-submission-form?prid=185358&wire=3

KD investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Kyndryl’s financial statements issued during the class period were materially misstated; (2) Kyndryl lacked adequate internal controls and at times materially understated issues with its internal controls; (3) as a result, Kyndryl would be unable to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025; and (4) as a result, defendants’ statements about Kyndryl’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

WHAT’S NEXT? If you suffered a loss in Kyndryl during the relevant time frame, you have until April 13, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Institutional investors holding positions in Apollo Global Management, Inc. (NYSE: APO) during the period May 10, 2021 through February 21, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

APO shares declined approximately $5.99 per share following corrective disclosures revealing that senior leadership allegedly maintained undisclosed business communications with Jeffrey Epstein throughout the 2010s. The Court has set May 1, 2026 as the deadline to apply for lead plaintiff appointment.

Fiduciary Obligations and Recovery Options

Fiduciaries with APO holdings during the Class Period should consider the following:

• Pension funds and asset managers owe a duty to evaluate potential recoveries on behalf of beneficiaries when portfolio companies are subject to securities fraud allegations
• Lead plaintiffs direct the litigation on behalf of the entire class and may select counsel, negotiate settlements, and oversee case strategy
• Serving as lead plaintiff requires no out-of-pocket cost; attorneys’ fees are paid only from any recovery obtained
• Institutional investors with the largest financial interest in the relief sought are given preference under the PSLRA’s lead plaintiff selection process
• Failure to evaluate a lead plaintiff opportunity may itself raise questions about fiduciary diligence

Contact us for institutional recovery options
or call (212) 363-7500.

Portfolio Impact Assessment

The lawsuit contends that Apollo Global repeatedly incorporated by reference the findings of a 2021 independent review into its quarterly and annual SEC filings, reiterating that the Company had no business dealings with Epstein. These filings, signed with Sarbanes-Oxley certifications, allegedly created artificial confidence in the integrity of management and the firm’s reputational standing. When corrective articles emerged in February 2026, institutional holders absorbed material portfolio losses as APO shares fell from above $119 to $113.73.

Case Summary

The securities action asserts that Apollo Global and certain officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by concealing the extent of senior leadership’s interactions with Epstein on substantive business matters, including tax strategy, a potential overseas redomiciliation, and an internal share offering for Athene Holding.

“Institutional investors play a critical role in securities class actions. Their participation ensures that cases are prosecuted effectively and that recoveries are maximized for all class members who relied on the integrity of Apollo Global’s public disclosures.” — Joseph E. Levi, Esq.

INSTITUTIONAL INVESTOR REPRESENTATION — Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Atara Biotherapeutics, Inc. (“Atara Biotherapeutics, Inc.” or the “Company”) (NASDAQ: ATRA) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Atara Biotherapeutics, Inc. investors who were adversely affected by alleged securities fraud between May 20, 2024 and January 9, 2026. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/atara-biotherapeutics-inc-lawsuit-submission-form?prid=185357&wire=3

ATRA investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) certain manufacturing issues, as well as deficiencies inherent in the ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel’s regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical trials; (iv) all the foregoing was likely to have a significant negative impact on Atara’s business and financial condition; and (v) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in Atara Biotherapeutics, Inc. during the relevant time frame, you have until May 22, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — “Leading integrated security provider” with “strong year over year growth going forward.” That was the promise. A stock that crashed 80% in a single day and fell from a peak of $31.06 to below $2.00, on the back of an alleged pump-and-dump scheme targeting retail investors. That was the reality.

Levi & Korsinsky, LLP alerts shareholders of Concorde International Group, Ltd. (NASDAQ: CIGL) that a securities class action has been filed covering purchases between April 21, 2025 and July 14, 2025. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

CIGL shares lost at last $29 per share from peak to trough, a decline exceeding 90%. The lead plaintiff deadline is May 18, 2026.

The Promise

Throughout the Class Period, the Company projected confidence and momentum to investors:

• The IPO prospectus described Concorde as “the leading solution provider in Singapore” with patented technology capable of servicing “15 or more buildings or locations” per unit
• Management touted a strategic shift toward a “tech-integrated model” and projected international expansion to “Malaysia, Australia, and North America” within 24 months
• A June 2025 announcement claimed $9.04 million in new contracts from January through May 2025, allegedly surpassing the total value of all contracts signed in 2024
• Management characterized the contracts as “multi-year recurring revenue” to be recognized over 2025 through 2029

The Reality

The lawsuit contends that behind these optimistic projections, the Company’s stock price was being artificially driven by a coordinated manipulation campaign, not fundamental value:

• CIGL shares surged from a $4.00 IPO price to $31.06 with no fundamental developments justifying the increase
• The Company’s actual revenue was flat at $10.5 million for 2024 compared to $10.7 million in 2023
• Operating loss reached $83.6 million in 2024 versus operating profit of $1.0 million in 2023
• The IPO floated less than 3% of total shares while one insider retained 97.57% of voting power

The Numbers: Promised vs. Actual

What Was Projected	What Occurred
“Strong year over year growth”	Revenue declined 1.5% year over year
“Capital foundation to accelerate [its] next phase of growth”	IPO raised $5.75M; operating loss hit $83.6M
Market cap exceeding $700 million	Stock collapsed to approximately $2.00 per share
“Validates our business model”	Alleged pump-and-dump scheme unraveled
International expansion within 24 months	No partners signed; Singapore represented 99% of clients

What the Action Alleges About the Gap

The complaint charges that the gulf between promise and reality was not accidental. According to the filing, impersonators posing as legitimate financial advisors promoted CIGL through online forums and social media with “sensational but baseless claims” designed to create a buying frenzy. The action further contends that the Company’s IPO architecture, with its minimal float and concentrated insider control, mirrored structures used in other Nasdaq micro-cap manipulation schemes that had already drawn regulatory scrutiny.

Check whether you qualify for the Concorde recovery action or call (212) 363-7500.

“Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections. When a stock price is disconnected from underlying fundamentals by a factor of nearly eight times, and the Company issues no cautionary disclosure, shareholders deserve answers.” — Joseph E. Levi, Esq.

LEAD PLAINTIFF DEADLINE: May 18, 2026

Submit your information to pursue recovery in the CIGL action or contact Joseph E. Levi, Esq. at (212) 363-7500.

Levi & Korsinsky, LLP is a nationally recognized shareholder rights firm. Over the past 20 years, the firm has secured hundreds of millions of dollars for aggrieved shareholders. Ranked in ISS Top 50 for seven consecutive years.

CONTACT:\

Levi & Korsinsky, LLP\

Joseph E. Levi, Esq.\

Ed Korsinsky, Esq.\

33 Whitehall Street, 27th Floor\

New York, NY 10004\

[email protected]\

Tel: (212) 363-7500\

Fax: (212) 363-7171

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Institutional investors holding positions in Driven Brands Holdings Inc. (NASDAQ: DRVN) during the period between May 9, 2023, and February 24, 2026, may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

DRVN shares lost nearly 40% of their value in a single session, declining $6.62 per share to close at $9.99 on February 25, 2026, after the Company disclosed sweeping material errors across nearly three years of consolidated financial statements. The Court has set May 8, 2026 as the deadline to apply for lead plaintiff appointment.

Notice to Institutional Holders

Pension funds, mutual funds, hedge funds, and other institutional holders that maintained DRVN positions during the Class Period face potential portfolio losses stemming from the Company’s alleged multi-year financial misstatements. A securities class action has been filed in the United States District Court for the Southern District of New York asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

The action contends that Driven Brands issued materially inaccurate financial statements from fiscal year 2023 through the third quarter of fiscal year 2025, overstating revenue and cash while understating operating expenses due to an unreconciled cash balance originating in 2023. On February 25, 2026, the Company disclosed at least ten categories of errors requiring restatement across approximately two years of financial reporting.

ERISA and Fiduciary Considerations

Institutional fiduciaries should be aware of the following considerations:

• Funds holding DRVN common stock purchased between May 9, 2023, and February 24, 2026, may qualify as class members in this action
• Lead plaintiff appointment allows institutional investors to select counsel, shape litigation strategy, and oversee settlement negotiations on behalf of the class
• Institutions with the largest financial interest in the relief sought are given preference under the Private Securities Litigation Reform Act
• Serving as lead plaintiff requires no out-of-pocket costs; attorneys’ fees are paid from any recovery obtained for the class
• Fiduciaries have an obligation to evaluate available legal remedies to recover losses for plan beneficiaries and fund participants
• Institutions that do not seek lead plaintiff status remain absent class members and retain the right to share in any recovery

Contact us for institutional recovery options
or call Joseph E. Levi, Esq. at (212) 363-7500.

Portfolio Impact Assessment

“Institutional investors play a critical role in securities class actions. Their participation ensures that the class is represented by sophisticated parties with substantial losses and the resources to oversee complex litigation on behalf of all shareholders who were harmed by allegedly inaccurate financial disclosures,” stated Joseph E. Levi, Esq., managing partner of Levi & Korsinsky, LLP.

The complaint details that PricewaterhouseCoopers LLP, the Company’s independent auditor, reported that Driven Brands’ financial statements and internal control over financial reporting should not be relied upon. As alleged, the Company’s own management conceded material weaknesses in internal controls as of December 27, 2025.

Case Summary

The securities action alleges that Driven Brands issued false and misleading SEC filings throughout the Class Period, including quarterly 10-Q reports and annual 10-K filings that contained overstated revenue figures, inflated cash balances, and understated selling, general, and administrative expenses.

INSTITUTIONAL INVESTOR REPRESENTATION — Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Institutional investors holding positions in EOS Energy Enterprises, Inc. (NASDAQ: EOSE) during the period November 5, 2025 through February 26, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

EOSE shares fell $4.39 per share, a 39.4% single-day decline, on February 26, 2026 after the Company reported full year 2025 revenue of $114.2 million against previously affirmed guidance of $150 million to $160 million. The window to apply for lead plaintiff closes on May 5, 2026.

Fiduciary Obligations and Recovery Options

Fund managers and plan fiduciaries with EOSE holdings during the Class Period should assess whether participation in this action is consistent with their obligations to beneficiaries. The lawsuit asserts that between November 5, 2025 and February 26, 2026, the Company’s securities traded at artificially inflated prices due to alleged misrepresentations about manufacturing capacity and production readiness.

• Fiduciaries holding EOSE shares may have an obligation to evaluate recovery options on behalf of fund beneficiaries
• Serving as lead plaintiff allows institutional holders to select counsel, oversee litigation strategy, and protect beneficiary interests
• Lead plaintiff appointment carries no out-of-pocket cost to the institution or its beneficiaries
• Institutions with the largest financial interest in the recovery are typically appointed by the Court
• Passive class members retain the right to share in any recovery without serving as lead plaintiff
• Portfolio losses tied to the 39.4% single-day decline may be recoverable under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934

Contact us for institutional recovery options
or call (212) 363-7500.

Portfolio Impact Assessment

The complaint contends that EOSE reached a Class Period high of $19.19 on November 10, 2025, fueled by the Company’s assertions about production ramp progress and revenue guidance reaffirmation. The action claims that undisclosed manufacturing failures, including equipment downtime in the mid-30% range versus a 10% industry benchmark, rendered those representations materially misleading. Institutional portfolios that accumulated or held positions based on those representations may have absorbed significant losses when the corrective disclosure emerged.

“Institutional investors play a critical role in securities class actions. Their participation helps ensure vigorous representation of the entire class and that recovery efforts are conducted with the diligence and oversight that all shareholders deserve.” — Joseph E. Levi, Esq.

Case Summary

The securities action, filed in the United States District Court for the District of New Jersey, alleges that the Company and certain officers made materially false and misleading statements regarding production capabilities, automation progress, and fiscal year 2025 revenue guidance. As pleaded, these misrepresentations artificially inflated the price of EOSE securities throughout the Class Period, and the February 26, 2026 corrective disclosure caused substantial shareholder harm.

Request a confidential portfolio impact review
or contact Joseph E. Levi, Esq. at (212) 363-7500.

INSTITUTIONAL INVESTOR REPRESENTATION — Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212) 363-7500

Fax: (212) 363-7171

EVANSVILLE, Ind., April 13, 2026 (GLOBE NEWSWIRE) — Old National Bancorp (NASDAQ: ONB) today announced a strategic alignment of its Commercial Banking leadership structure to better match leadership roles and responsibilities with the capabilities, reach, and complexity of its commercial clients. As part of this updated structure, Chris Doyle has joined Old National as President of Commercial Banking, and John C. Thurston has been promoted to President of Corporate Banking.

“We are thrilled to welcome Chris to Old National, and we are equally excited to welcome John into an expanded leadership role,” said Old National Chairman and CEO Jim Ryan. “This new alignment not only allows us to fully leverage the strengths and experience of both leaders, it also reflects the growing scale of our Commercial business and our commitment to providing exceptional, highly individualized service to all our commercial clients.”

Additionally, Old National is further aligning key Treasury Management and Commercial middle office functions. Joe Wicklander, president of Treasury Solutions & Payments, will continue to lead Treasury Management, Merchant Services, and the Financial Institutions Group while also taking on responsibility for Old National’s Foreign Exchange (FX) business and building out FinTech and Liquidity solutions. Tim Kocher will transition from Chief Credit Strategy Officer to Chief Service Delivery Officer, providing leadership that strengthens service delivery for Commercial Banking clients.

These leadership updates follow the departure of Commercial Banking CEO Jim Sandgren, who retired on April 1, 2026, after 34 years of service with the organization.

About Chris Doyle

Old National welcomes Chris Doyle as President of Commercial Banking. Doyle brings more than 20 years of banking experience, most recently serving as Commercial Regional Leader, SVP, at a super-regional bank, where he spent nine years supporting complex client transactions, growth strategies, capital needs, and succession planning.

In this new leadership role, Doyle will oversee Commercial & Industrial (C&I) Banking (including SBA lending and Agricultural lending), Middle Market Banking (including Asset-Based Lending, Small Business Investment Company, and Family Office), Commercial Real Estate and Expansion Markets.

Doyle is active in the local Cleveland-area community where he serves as a board member of Urban Community School (Board Chair), Boys and Girls Clubs of Greater Cleveland, Cleveland Clinic Children’s Hospital, and GESU Finance Council. He is also a member of Leadership Cleveland class of 2026. Chris earned a Bachelor of Business Administration in Finance from Saint Louis University.

About John C. Thurston

John C. Thurston, who joined Old National in 2023 and most recently served as Corporate Banking Director, has been appointed President of the Corporate Bank, which will serve Old National’s largest commercial banking clients. Thurston brings 30 years of industry experience spanning multiple geographies, lines of business, and industry verticals.

He has led teams across the country while driving strategic initiatives, new business development, and long‑term client growth strategies. In his expanded leadership role, Thurston will oversee Corporate Banking, Specialty Banking, and Capital Markets (including Syndications, Tax Credit, Term Loan B, Sponsor Finance, and Investment Banking/M&A).

A resident of Chicago for more than 30 years, John is highly active in the Chicago community, serving as a member of the Board of Directors at Christ the King Jesuit College Prep, as well as a Board Member at Mercy Home for Boys and Girls. He is the past Chairman of the Old St. Mary’s Church Finance Committee, and a member of the Old St. Mary’s School Finance Sub-committee and Amate House Board of Directors. John earned a Bachelor of Business Administration and Bachelor of Arts in Finance and Business Economics from the University of Notre Dame.

About Joe Wicklander

As President of Treasury Solutions & Payments, Joe Wicklander has modernized and enhanced Old National’s Treasury Management and Merchant Services offerings while also launching a Financial Institutions Group. He will continue to lead Treasury Management, Merchant Services, and the Financial Institutions Group with added responsibility for Old National’s Foreign Exchange (FX) business. Prior to joining Old National in 2023, he led the Financial Institutions Group for CIBC Bank in Chicago.

About Tim Kocher
Tim Kocher will transition from Chief Credit Strategy Officer to Chief Service Delivery Officer, providing operational leadership that strengthens service delivery for Commercial Banking clients. In this role, he will oversee Commercial Administration (including loan fulfillment and commercial support) and Treasury Management middle office functions, helping ensure consistent execution, strong controls, and a seamless client experience. Formerly a member of Bremer Bank’s executive leadership team, Kocher officially transitioned to Old National’s leadership with the completion of the bank’s Bremer Bank partnership in 2025.

ABOUT OLD NATIONAL


Old National Bancorp (NASDAQ: ONB) is the holding company of Old National Bank. As the sixth largest commercial bank headquartered in the Midwest, Old National proudly serves clients primarily in the Midwest and Southeast. With approximately $72 billion of assets and $37 billion of assets under management, Old National ranks among the top 25 banking companies headquartered in the United States. Tracing our roots to 1834, Old National focuses on building long-term, highly valued partnerships with clients while also strengthening and supporting the communities we serve. In addition to providing extensive services in consumer and commercial banking, Old National offers comprehensive wealth management and capital markets services. For more information and financial data, please visit Investor Relations at oldnational.com. In 2025, Points of Light named Old National one of “The Civic 50” – an honor reserved for the 50 most community-minded companies in the United States.

Investor Relations:

Lynell Durchholz
(812) 464-1366
[email protected] 

Media Relations:

Rick Vach
(904) 535-9489
[email protected]